v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Total Revenues $ 149,157 $ 74,890 $ 71,348
Total Cost of revenues 76,849 20,729 19,643
Gross profit 72,308 54,161 51,705
Operating expenses:      
Sales and marketing 47,458 45,631 47,318
General and administrative 49,702 30,322 25,426
Research and development 6,584 12,771 9,515
Total operating expenses 103,744 88,724 82,259
Loss from operations (31,436) (34,563) (30,554)
Other (income) expense:      
Interest expense 8,415 7,286 5,424
Loss on extinguishment of debt   4,427  
Other income, net (716) (2,549) (5,789)
Net loss (39,135) (43,727) (30,189)
Less: Net loss attributable to non-controlling interest (137) (19)  
Net loss attributable to Neuronetics stockholders' $ (38,998) $ (43,708) $ (30,189)
Net loss per share of common stock outstanding, basic attributable to Neuronetics stockholders' $ (0.59) $ (1.38) $ (1.05)
Net loss per share of common stock outstanding, diluted attributable to Neuronetics stockholders' $ (0.59) $ (1.38) $ (1.05)
Weighted average common shares outstanding, basic (in shares) 65,951 31,734 28,658
Weighted average common shares outstanding, diluted (in shares) 65,951 31,734 28,658
Products and Other      
Total Revenues $ 62,180 $ 70,445 $ 71,348
Total Cost of revenues 16,464 17,516 $ 19,643
Services      
Total Revenues 86,977 4,445  
Total Cost of revenues $ 60,385 $ 3,213